about
Genome-wide association analysis identifies new susceptibility loci for Behçet's disease and epistasis between HLA-B*51 and ERAP1Targeted resequencing implicates the familial Mediterranean fever gene MEFV and the toll-like receptor 4 gene TLR4 in Behçet diseaseNeurological manifestations of Behçet's disease in Japan: a study of 54 patients.Behçet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicityGenome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behçet's disease.Diagnostic test accuracy of ultrasound for synovitis in rheumatoid arthritis: systematic review and meta-analysis.Association of reduced heme oxygenase-1 with excessive Toll-like receptor 4 expression in peripheral blood mononuclear cells in Behçet's disease.Continuous evolution of clinical phenotype in 578 Japanese patients with Behçet's disease: a retrospective observational studyA single endoplasmic reticulum aminopeptidase-1 protein allotype is a strong risk factor for Behçet's disease in HLA-B*51 carriers.Genetic architectures of seropositive and seronegative rheumatic diseases.Distinct clinical features between acute and chronic progressive parenchymal neuro-Behçet disease: meta-analysis.Dense genotyping of immune-related loci implicates host responses to microbial exposure in Behçet's disease susceptibility.Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis.(18)F-FDG and (18)F-NaF PET/CT demonstrate coupling of inflammation and accelerated bone turnover in rheumatoid arthritis.Predicting joint destruction in rheumatoid arthritis with power Doppler, anti-citrullinated peptide antibody, and joint swelling.Ultrasonography predicts achievement of Boolean remission after DAS28-based clinical remission of rheumatoid arthritis.Multiple extra-articular synovial cysts complicated with rheumatoid arthritis.Screening of tuberculosis by interferon-gamma assay before biologic therapy for rheumatoid arthritis.Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still's disease: A multicenter retrospective study.Clinical manifestations of Behçet's disease depending on sex and age: results from Japanese nationwide registration.The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease.Regional cerebral glucose metabolism in systemic lupus erythematosus patients with major depressive disorder.A polymorphism in CCR1/CCR3 is associated with narcolepsy.Circulating carbon monoxide level is elevated after sleep in patients with obstructive sleep apnea.Dysfunction of TRIM21 in interferon signature of systemic lupus erythematosus.Non-IgG4-related Multifocal Fibrosclerosis.Systemic sclerosis and pseudomesotheliomatous adenocarcinoma of the lung.On-demand ultrasonography assessment in the most symptomatic joint supports the 8-joint score system for management of rheumatoid arthritis patients.Tumor necrosis factor alpha acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytes.Dysregulated heme oxygenase-1low M2-like macrophages augment lupus nephritis via Bach1 induced by type I interferons.GWAS-identified CCR1 and IL10 loci contribute to M1 macrophage-predominant inflammation in Behçet's disease.Bach1 regulates osteoclastogenesis in a mouse model via both heme oxygenase 1-dependent and heme oxygenase 1-independent pathwaysHaploinsufficiency of A20 caused by a novel nonsense variant or entire deletion of TNFAIP3 is clinically distinct from Behçet's disease.Genetic determinants and an epistasis of LILRA3 and HLA-B*52 in Takayasu arteritis.Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximabChemical induction of HO-1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti-dsDNA antibodyA novel 8-joint ultrasound score is useful in daily practice for rheumatoid arthritisMusculoskeletal ultrasonography delineates ankle symptoms in rheumatoid arthritisClinical features of early-stage possible Behçet's disease patients with a variant-type major organ involvement in JapanDose down-titration of biological disease-modifying antirheumatic drugs in daily clinical practice: Shared decision-making and patient treatment preferences in Japanese patients with rheumatoid arthritis
P50
Q28943506-951E7950-F3AB-4BA0-951B-F49EEC50C24EQ30447248-458CE464-98C9-4DBD-A86B-A9C912966F84Q33529166-8013753A-CDF3-483A-8EF9-3DFFDDD72C7CQ33789950-934E2929-0BBC-4F00-9DC5-57E6C6EF34BAQ34073780-EAB23756-A681-48C6-B153-06BD1137D186Q36322318-B2C69A34-92D3-4EA6-8758-CE506E3DA590Q36641604-B42B922E-2A95-4262-A57F-D6A7413A7891Q37307544-D36D9901-8799-4624-9D5A-532B7FFC6EE2Q37409828-400925A4-CF52-45B4-A629-E241F4F622BEQ38439633-AB26B81A-6573-4727-BCB2-3DBF5287702BQ38599055-D6A33D2C-1E6D-4157-9925-10ED15D60477Q38976440-41F73365-AB99-4840-8EEF-52CB7F1D471DQ40298252-B45317DE-32D0-4CB2-B45D-4E6545C9C808Q40770857-44E10231-F979-405D-95EC-562AD5F30B3BQ41452476-0C876D1A-E840-442A-9651-B8CBEA82E4D0Q43978434-1DA7C25F-743B-4207-A23C-758E44E18E1AQ45969384-59B4F0BD-9D63-459D-BA31-783678ED0E03Q46124801-A1410C4A-679C-4F43-A1CB-E0C8CAB9C0B4Q47248914-41632278-41F1-438D-9EFE-CCC65C34C58CQ47623062-5BAA208B-AA53-4966-9A22-075AAD11732CQ47659489-AEBDD08A-5C80-4238-B85A-1D8C24CEEED2Q47695436-CFD69F45-9187-43CD-8E8B-E28630EBB1E4Q47972241-CBF546D0-1E22-4E66-8959-C72E142F63B4Q48419530-DA437686-A11F-431C-84DB-8F853975BC18Q49549253-6A52F269-6E65-4063-9862-AD982486F8F9Q51540395-B5467FBF-AA75-4A06-A6F4-08CD57E5EFB3Q53534144-64CE2F5D-2CD6-40E6-B35F-0B03EF1F15DCQ54484459-AC355634-0EDE-4AC7-90A6-93B19E164B5DQ54559145-E3A4B37C-0F53-477B-9421-6E88DCC3C584Q55027053-F36135FC-E1CF-4EE5-B0FD-63916449A728Q55385001-EC0A04E2-6082-4E4E-B6F8-73F7D7343149Q62746891-30196A1B-5A56-4C4B-9947-2BF9E122CE4DQ64885040-81452A2B-8C4F-4D73-A8DE-D920B93D82BDQ64885278-21D7B42A-5D7F-44D3-A86C-098342288978Q80860166-D6C2E059-301F-46FD-A0C9-2C808BA7E33DQ80892695-FF3F1B52-D1A0-4BAC-931B-AD9150CBD051Q85984018-D678B507-398A-4D48-A4CA-F4DD0C4912C0Q88157168-A52A827B-7858-4814-8592-44B04D5B7ABDQ89315733-6104CF58-A1EA-425D-8C9A-EEF2DBB44791Q90085596-8C7DC051-358B-417B-A713-8566DF2573EC
P50
description
researcher ORCID: 0000-0002-9488-661X
@en
wetenschapper
@nl
name
Yohei Kirino
@ast
Yohei Kirino
@en
Yohei Kirino
@es
Yohei Kirino
@nl
Yohei Kirino
@sl
type
label
Yohei Kirino
@ast
Yohei Kirino
@en
Yohei Kirino
@es
Yohei Kirino
@nl
Yohei Kirino
@sl
prefLabel
Yohei Kirino
@ast
Yohei Kirino
@en
Yohei Kirino
@es
Yohei Kirino
@nl
Yohei Kirino
@sl
P108
P1053
B-3701-2009
P106
P31
P3829
P496
0000-0002-9488-661X
P569
2000-01-01T00:00:00Z